[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363406-105":59,"doc-detail-363406-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","immunohistochemistry-as-a-cornerstone-in-lung-cancer-diagnosis-subtyping-based-on-the-2021-world-health-organization-classification-and-its-practical-application","Immunohistochemistry as a Cornerstone in Lung Cancer Diagnosis - Subtyping Based on the 2021 World Health Organization Classification and Its Practical Application","","Lung cancer causes the highest cancer-related mortality worldwide, and accurate histological classification is essential for therapy selection. Immunohistochemistry (IHC) improves diagnostic reliability when limited tissue is available from small biopsies. This prospective study analyzed 151 lung biopsy specimens over 18 months to evaluate the diagnostic performance of IHC markers for WHO 2021-aligned subtyping and to distinguish primary from metastatic lesions. Results show strong marker specificity, concordance between lineage markers, and clear exclusion of extrapulmonary metastasis based on TTF-1 status.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immunohistochemistry-as-a-cornerstone-in-lung-cancer-diagnosis-subtyping-based-on-the-2021-world-health-organization-classification-and-its-practical-application/363406/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immunohistochemistry-as-a-cornerstone-in-lung-cancer-diagnosis-subtyping-based-on-the-2021-world-health-organization-classification-and-its-practical-application/363406.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"Why is immunohistochemistry important for lung cancer diagnosis in this study?","Question",{"text":112,"@type":113},"IHC enhances accuracy when diagnostic material is limited, such as in small biopsy samples, supporting more precise histological classification and treatment-relevant subtyping.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the study conducted and what was the sample size?",{"text":117,"@type":113},"A prospective study evaluated 151 lung biopsy specimens collected over 18 months, using a defined IHC panel and additional markers for metastatic differentiation.",{"name":119,"@type":110,"acceptedAnswer":120},"Which IHC markers were most specific for adenocarcinoma and squamous differentiation?",{"text":121,"@type":113},"TTF-1 and napsin A were highly specific for adenocarcinoma (85% and 94%, respectively). CK5/6 and P63 confirmed squamous differentiation with 100% positivity.",{"name":123,"@type":110,"acceptedAnswer":124},"How did the approach help differentiate primary lung tumors from metastatic lesions?",{"text":125,"@type":113},"The study applied additional markers for metastatic differentiation and found all metastatic lesions were TTF-1 negative, supporting an extrapulmonary origin.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},363406,1790222741,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Original Article World J Oncol. 2026;17(3):419-427  \nImmunohistochemistry as a Cornerstone in Lung Cancer Diagnosis: Subtyping Based on the 2021 World Health Organization Classification and Its Practical Application  \nImrana Tanvira, Amber Hassanb, l, Bushra Nisarc, Sadia Khand, Maryam Altafd, Humaira Waseeme, Hussain Noorwalif, Ali A. Mousag, Amany Fathaddinh, Ragdah Arifi,  \nMohammed M. Karamij, Majid Almansourik, l  \nAbstract  \nBackground: Lung cancer is the leading cause of cancer-related deaths worldwide, and precise histological classification is vital for therapy decisions. Given diagnostic limitations with small biopsies, immunohistochemistry (IHC) enhances accuracy. This study evaluated the diagnostic value of IHC markers in subtyping lung tumors per the 2021 World Health Organization (WHO) classification and differentiating primary from metastatic lesions.  \nMethods: A prospective study was conducted on 151 lung biopsy specimens over 18 months. All samples were processed using  \nManuscript submitted March 3, 2026, accepted April 15, 2026  \nPublished online May 8, 2026  \naDepartment of Pathology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia  \nbEuropean School of Molecular Medicine, University of Milan, Milan, Italy cAmeerudeen Medical College/PGMI/LGH Lahore, Lahore, Pakistan  \ndBPP University, Manchester, UK  \neFatima Jinnah Medical University, Lahore, Pakistan  \nfDepartment of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia  \ngDepartment of Anatomy and Embryology, Faculty of Medicine, JoufUniversity, Jouf, Saudi Arabia  \nhDepartment of Pathology, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia  \niDepartment of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia  \njDepartment of Clinical Physiology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia  \nkDepartment of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia  \nlCorresponding Authors: Majid Almansouri, Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. [Email: Majid.Almansouri@hotmail.com](Email: Majid.Almansouri@hotmail.com); Amber Hassan, European School of Molecular Medicine, University of Milan, Milan, Italy.  \n[Email: AmberHassan7@gmail.com](Email: AmberHassan7@gmail.com)  \ndoi: [https://doi.org/10.14740/wjon2757](https://doi.org/10.14740/wjon2757)  \nWorld Journal of Oncology  \n1920-4531 (print), 1920-454X (online)  \nstandard histopathological techniques and an IHC panel comprising thyroid transcription factor-1 (TTF-1), napsinA, cytokeratin (CK)7, CK5/6, P63, synaptophysin, and chromogranin. Additional markers (estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), PAX-8, PAX-2, CD10) were applied for metastatic differentiation. Statistical correlation analysis between lineage-specific markers was performed to assess diagnostic concordance.  \nResults: Adenocarcinoma was the most prevalent subtype (58.3%), followed by neuroendocrine neoplasms (17.2%), metastatic lesions (13.2%), adenosquamous carcinoma (6.0%), and squamous cell carcinoma (2.6%) . Rare entities included carcinosarcoma and mucoepidermoid carcinoma (each 1.3%) . TTF-1 and napsin A were highly specific for adenocarcinoma (85% and 94%, respectively), whereas CK5/6 and P63 confirmed squamous differentiation (100% each) . Synaptophysin and chromogranin were positive in 96% and 100% of neuroendocrine tumors, respectively. Correlation analysis demonstrated strong marker concordance: TTF-1 vs napsin A (r = 0.88, P \u003C 0.001), P63 vs CK5/6 (r = 0.93, P \u003C 0.001), and synaptophysin vschromogranin (r = 0.87, P \u003C 0.001). All metastatic lesions were TTF-1 negative, confirming their extrapulmonary origin.  \nConclusions: Combining IHC with histopathology markedly improves diagnostic precision and consistency in lung tumor classification","cbCaicvl0vUWunRt","https://ap.wps.com/l/cbCaicvl0vUWunRt","pdf",1920622,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n# Keywords","[{\"question\":\"Why is immunohistochemistry important for lung cancer diagnosis in this study?\",\"answer\":\"IHC enhances accuracy when diagnostic material is limited, such as in small biopsy samples, supporting more precise histological classification and treatment-relevant subtyping.\"},{\"question\":\"How was the study conducted and what was the sample size?\",\"answer\":\"A prospective study evaluated 151 lung biopsy specimens collected over 18 months, using a defined IHC panel and additional markers for metastatic differentiation.\"},{\"question\":\"Which IHC markers were most specific for adenocarcinoma and squamous differentiation?\",\"answer\":\"TTF-1 and napsin A were highly specific for adenocarcinoma (85% and 94%, respectively). CK5/6 and P63 confirmed squamous differentiation with 100% positivity.\"},{\"question\":\"How did the approach help differentiate primary lung tumors from metastatic lesions?\",\"answer\":\"The study applied additional markers for metastatic differentiation and found all metastatic lesions were TTF-1 negative, supporting an extrapulmonary origin.\"}]","Immunohistochemistry as a Cornerstone in Lung Cancer Diagnosis - Subtyping Based on the 2021 World Health Organization Classification and Its Practical Application | PDF",1790151090,23,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95f2e157c9fb5c49ace1c72c71eece14.webp",983,1272,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5ef15fa7adcaf7249550330109da221.webp",982,1270,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/825b241815bcdd4dc1c3b41c88a3523e.webp",981,1269,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1ae99baf8814917a297fd5259a52da2.webp",980,1268]